Skip to main content

Table 1 Characteristics of the patient cohort

From: Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

  JAK2 Age Gender WBC (109/L) Hb (g/L) Plt (109/L) Blasts (%) LDH (U/L)
  mut wt   m f      
CML (n = 10) 0 10 55 9 1 81.3 107 219 1 599
PV (n = 10) 8 2 56 4 6 12.4 133 370 0 259
ET (n = 10) 5 5 69 3 7 8.2 130,5 770 0 267
MF (n = 27) 14 13 67 12 15 10.1 104,5 376 0,5 431
Total 27 30 66 28 29 11.7 114 338 0 369
  1. Median values for age, WBC, Hb, Plt, Blasts, LDH. CML, Chronic myeloid leukemia, ET, essential thrombocythemia; Hb, hemoglobin; LDH, lactate dehydrogenase; MF, myelofibrosis; mut, positive for JAK2V617F; plt, platelet count; PV, polycythemiavera; WBC, white blood cell count; wt = negative for JAK2V617F.